Clinical Trials in Illinois

Showing 18321-18340 of 19,692 trials

Study of Daclizumab in Patients With Chronic, Persistent Asthma

NCT00028288

The purpose of the study is to evaluate an investigational medication to treat chronic persistent asthma. The research is being conducted at up to 22 clinical research sites in the US and is open to both men and women ages 18 to 70 years old. Participants in the study will have a number of visits to a research site over a 10-month period. All study-related care and medication is provided to qualified participants at no cost: this includes all visits, examinations and laboratory work.

Asthma

Facet Biotech120 participantsStarted Sep 2001

Long Beach, California, United States • Mission Viejo, California, United States • San Diego, California, United States +15 more locations

TERMINATEDPhase 211 miles

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

NCT00657137

This study will compare the anti-tumor efficacy of apricoxib and lapatinib/capecitabine with placebo and lapatinib/capecitabine as measured by time to disease progression and evaluate urinary PGE-M measurements or baseline COX-2 expression in tumor tissue by IHC as a surrogate selection criterion for patients who will benefit from future treatment with apricoxib.

Breast Cancer

Tragara Pharmaceuticals, Inc.12 participantsStarted Apr 2008

Tucson, Arizona, United States • Bakersfield, California, United States • Berkeley, California, United States +41 more locations

Study of Daclizumab in Patients With Chronic, Persistent Asthma

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

Find Trials by Condition in Illinois

Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles

Use of Cold and Compression Therapy With Total Knee Replacement Patients

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

Study of Decision Making in Patients Participating in Phase I Clinical Trials

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

ETEC Logistics Trial (TREK)

An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

SD Cystic Fibrosis Study

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study